Distinguished in Sjogren Syndrome

Dr. Ghaith Noaiseh

Rheumatology
The University of Kansas Hospital
Kansas University Physicians Inc
4000 Cambridge St, 
Kansas City, KS 
Accepting New Patients
Offers Telehealth
Distinguished in Sjogren Syndrome
The University of Kansas Hospital
Kansas University Physicians Inc
4000 Cambridge St, 
Kansas City, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ghaith Noaiseh is a Rheumatologist in Kansas City, Kansas. Dr. Noaiseh is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Sjogren Syndrome, Interstitial Keratitis, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Noaiseh is currently accepting new patients.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Sjogren Syndrome.

Specialties
Rheumatology
Licenses
Internal Medicine in MO
Hospital Affiliations
Olathe Medical Center
University Of Kansas Hospital
Languages Spoken
English
Arabic
Hindi
Japanese
Mandarin
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

KANSAS UNIVERSITY PHYSICIANS INC
4000 Cambridge St, Kansas City, KS 66160
Other Locations
KANSAS UNIVERSITY PHYSICIANS INC
1000 E 101st Ter, Urology, Kansas City, MO 64131

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

12 Total Publications

Plain language summary: treatment of Sjögren's disease with dazodalibep.
Plain language summary: treatment of Sjögren's disease with dazodalibep.
Journal: Immunotherapy
Published: November 07, 2025
Similar Doctors
Advanced in Sjogren Syndrome
Dr. Vijay R. Mhatre
Rheumatology
Advanced in Sjogren Syndrome
Dr. Vijay R. Mhatre
Rheumatology
6001 Sw 6th Ave, Ste 320, 
Topeka, KS 
 (61.9 miles away)
785-232-4248
Languages Spoken:
English

Vijay Mhatre is a Rheumatologist in Topeka, Kansas. Dr. Mhatre is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Rheumatoid Arthritis (RA), and Sjogren Syndrome.

Advanced in Sjogren Syndrome
Dr. Christopher D. Koenig
Rheumatology
Advanced in Sjogren Syndrome
Dr. Christopher D. Koenig
Rheumatology

Kansas City Physician Partners Inc

17795 W 106th St, Suite 102, 
Olathe, KS 
 (12.9 miles away)
913-942-2848
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Koenig is a Rheumatologist in Olathe, Kansas. Dr. Koenig is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Raynaud Phenomenon, and Rhizomelic Pseudopolyarthritis. Dr. Koenig is currently accepting new patients.

Advanced in Sjogren Syndrome
Dr. Kalista T. Engelman
Rheumatology
Advanced in Sjogren Syndrome
Dr. Kalista T. Engelman
Rheumatology

Kansas City Physician Partners Inc

8350 N Saint Clair Ave, Suite 100, 
Kansas City, MO 
 (13.3 miles away)
913-258-2116
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kalista Engelman is a Rheumatologist in Kansas City, Missouri. Dr. Engelman is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Engelman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Noaiseh's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile